A Phase 1/2 Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck
20160 citationsJournal Articlebronze Open Access
Field-Weighted Citation Impact: 0.00
A Phase 1/2 Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck | Researchclopedia